Phlow Corp. Closes $20 Million Series A Financing to Further Essential Medicines Research and Development Programs and Advanced Manufacturing Initiatives

Date Published02/16/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Phlow Corp.
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2020
Year reshoring implemented or to be implemented:2021
Domestically, the work will be done:In-house
City reshored to:Richmond
State(s) reshored to:VA
If relevant, work nearshored to:-
Product(s) reshoredessential medicines, pharmaceutical products
What domestic positive factors made reshoring more attractive?Government Incentives, Infrastructure, Impact on domestic economy, Lean/other business process improvement techniques, Skilled workforce availability/training, Other, Covid-19, essential product supply
Government Incentive dollar amount:$812 million
Find Reshoring Articles